Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA
- Conditions
- HemiplegiaCerebrovascular Accident (CVA)Stroke
- First Posted Date
- 2017-02-15
- Last Posted Date
- 2020-04-07
- Lead Sponsor
- Parker Hannifin Corporation
- Target Recruit Count
- 48
- Registration Number
- NCT03054064
- Locations
- 🇺🇸
Cedars-Sinai Health System, Los Angeles, California, United States
🇺🇸Shepherd Center, Atlanta, Georgia, United States
🇺🇸Rehabilitation Institute of Chicago (Shirley Ryan AbilityLab), Chicago, Illinois, United States
Indego Exoskeleton After SCI
- Conditions
- Spinal Cord Injury
- First Posted Date
- 2016-06-08
- Last Posted Date
- 2018-08-31
- Lead Sponsor
- Parker Hannifin Corporation
- Target Recruit Count
- 9
- Registration Number
- NCT02793635
- Locations
- 🇺🇸
St. Charles Hospital, Port Jefferson, New York, United States
🇺🇸TIRR Memorial Hermann, Houston, Texas, United States
🇺🇸Sheltering Arms, Mechanicsville, Virginia, United States
Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).
- Conditions
- Spinal Cord Injury
- First Posted Date
- 2014-07-29
- Last Posted Date
- 2017-07-25
- Lead Sponsor
- Parker Hannifin Corporation
- Target Recruit Count
- 53
- Registration Number
- NCT02202538
- Locations
- 🇺🇸
Craig Hospital, Englewood, Colorado, United States
🇺🇸Shepherd Center, Atlanta, Georgia, United States
🇺🇸Rehabilitation Institue of Chicago, Chicago, Illinois, United States